Ticker: KROS

Company: Keros Therapeutics, Inc.

Person: BIENAIME JEAN JACQUES, director

Transaction date: April 15, 2026

Reporting date: April 17, 2026

Average share price: 11.7

Bought 1000.0 shares for 11700.0